Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-25

Clinical Trial Update: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether calcium gluconate and magnesium sulfate can prevent oxaliplatin-induced neurotoxicity in patients with colorectal cancer underg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CALCIUM GLUCONATE (Calcium gluconate)
  • Magnesium sulfate (magnesium sulfate)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Cancer, Neurotoxicity | Phase 3 | Status: COMPLETED | Results posted: 2013-03-25